Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | HPGD | P15428 | 2/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
| ▸ | MMP3 | P08254 | 1/20 | 0.54 |
| ▸ | MMP13 | P45452 | 1/20 | 0.54 |
| ▸ | MMP14 | P50281 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1382747 | 0.84 | PTGDR2 (0.73) | PTGDR2ALDH1A1SMN1; SMN2HPGDHTT | |
| SCHEMBL1752352 | 0.84 | PTGDR2 (0.72) | PTGDR2ALDH1A1SMN1; SMN2HPGDHTT | |
| SCHEMBL2557964 | 0.84 | PTGDR2 (0.72) | PTGDR2ALDH1A1SMN1; SMN2HPGDHTT | |
| SCHEMBL9695894 | 0.84 | PTGDR2 (0.72) | PTGDR2ALDH1A1SMN1; SMN2HPGDHTT | |
| SCHEMBL6687183 | 0.84 | PTGDR2 (0.72) | PTGDR2ALDH1A1SMN1; SMN2HPGDHTT | |
| SCHEMBL31428467 | 0.84 | PTGDR2 (0.72) | PTGDR2ALDH1A1SMN1; SMN2HPGDHTT | |
| SCHEMBL1287954 | 0.84 | PTGDR2 (0.72) | PTGDR2ALDH1A1SMN1; SMN2HPGDHTT | |
| SCHEMBL4350483 | 0.83 | PTGDR2 (0.71) | PTGDR2ALDH1A1SMN1; SMN2HPGDHTT | |
| SCHEMBL5304037 | 0.82 | PTGDR2 (0.70) | PTGDR2ALDH1A1SMN1; SMN2HPGDHTT | |
| SCHEMBL10051821 | 0.82 | PTGDR2 (0.68) | PTGDR2ALDH1A1SMN1; SMN2HPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613362-A | Preparation method of 3-amino-2, 3-dihydrobenzofuran compound | 江西师范大学 | 2025-03-14 | — | — | CN | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2020032813-A1 | NEW 5-SUBSTITUTED DERIVATIVES OF 5-HYDRAZINO-3-METHYLISOTHIAZOLE-4- ACID CARBOXYLIC ACID WITH ANTI-TUMOR ACTIVITY AND THE METHOD OF THEIR PREPARATION AND USES | UNIWERSYTET MEDYCZNY IM. PIASTÓW ŚLĄSKICH WE WROCŁAWIU (PL) | 2020-02-13 | — | — | WO | claimed |
| CN-105037269-B | Substituted pyrazolecarboxylic ketone secretory protease inhibitors and preparation method thereof | 中国人民解放军第二军医大学 | 2018-01-19 | — | — | CN | claimed |
| WO-2013175499-A2 | POLYMORPHIC FORM OF 5-(4-[4-(5-CYANO-1H-INDOL-3- YL)BUTYL]PIPERAZIN-1-YL) BENZOFURAN-2-CARBOXAMIDE | CADILA HEALTHCARE LIMITED (IN) | 2013-11-28 | — | — | WO | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-20070130702-A1 | Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative | L'OREAL S.A. | 2007-06-14 | — | — | US | claimed |
| US-7204857-B1 | Dyeing method using a specific active methylene compound and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative | L'OREAL S.A. (FR) | 2007-04-17 | — | — | US | claimed |
| EP-1215210-B1 | Benzofurans | MERCK PATENT GMBH (DE) | 2006-10-18 | — | — | EP | claimed |
| EP-0738722-A1 | 5-Amino-benzofuran-2-carboxylic acid derivatives | MERCK PATENT GmbH (DE) | 1996-10-23 | — | — | EP | claimed |
| EP-0630888-A1 | IMIDAZOLINE DERIVATIVE, PRODUCTION THEREOF, AND BLOOD PRESSURE RETENTIVE | Maeda, Hiroshi (JP) | 1994-12-28 | — | — | EP | claimed |
| US-4654435-A | WITH ORGANIC COMPOUNDS HAVING BOTH A CARBOXYL GROUP AND AN ALDEHYDE GROUP | NIPPON ZEON CO., LTD. (JP) | 1987-03-31 | — | — | US | claimed |
| EP-0087109-B1 | MODIFIED RUBBER COMPOSITION | NIPPON ZEON CO., LTD. (JP) | 1986-10-29 | — | — | EP | claimed |
| EP-0087110-B1 | PROCESS FOR MODIFYING RUBBERS | NIPPON ZEON CO., LTD. (JP) | 1986-10-29 | — | — | EP | claimed |
| US-4412031-A | CARBON BLACK | NIPPON ZEON CO., LTD. (JP) | 1983-10-25 | — | — | US | claimed |
| US-4412041-A | IN PRESENCE OF ACID CATALYSTS | NIPPON ZEON CO. LTD. (JP) | 1983-10-25 | — | — | US | claimed |
| EP-0087109-A1 | Modified rubber composition | NIPPON ZEON CO., LTD. (JP) | 1983-08-31 | — | — | EP | claimed |
| EP-0087110-A1 | Process for modifying rubbers | NIPPON ZEON CO., LTD. (JP) | 1983-08-31 | — | — | EP | claimed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070130702-A1 | Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative | KRT18, NDUFB5, NDUFB7 | PTGDR2 2441/4885ALDH1A1 83/4885SMN1; SMN2 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.